Introduction: In today’s fast-paced world, maintaining a healthy home environment is more important than ever. For families, especially those with young children, the quality of indoor air and the presence of mould can significantly impact health and well-being. Dr. Cameron Jones, an experienced microbiologist and CEO of Biological Health Services Pty Ltd, shares his extensive knowledge on how to ensure your home remains a safe haven. Additionally, with the recent emergence of mucormycosis in the context of COVID-19, understanding fungal threats has become crucial.
About Dr. Cameron Jones: Dr. Cameron Jones holds a PhD in microbiology and has been publishing academic literature for over 30 years. He is Australia's leading expert on mould and a regular guest on Channel 7 and various radio stations, where he discusses public health issues related to water damage and air quality. Dr. Jones also serves as an expert witness in property law cases, providing crucial insights into mould contamination and its impacts. His expertise is invaluable in resolving disputes and ensuring that properties meet health and safety standards.
Understanding the Importance of Indoor Air Quality: Indoor air quality (IAQ) is crucial for good health, particularly for children who spend a lot of time indoors. Poor IAQ can lead to respiratory issues, allergies, and other health problems. Dr. Jones emphasizes the importance of regular air quality assessments to identify and mitigate potential risks.
Common Sources of Indoor Air Pollutants: Dr. Jones identifies several common sources of indoor air pollutants:
- Mould and Mildew: Often resulting from water damage, mould spores can become airborne, causing respiratory issues.
- Chemicals: Household cleaning products, paints, and pesticides can release volatile organic compounds (VOCs) into the air.
- Dust and Pet Dander: These can exacerbate allergies and asthma, especially in young children.
Steps to Improve Indoor Air Quality:
- Regular Inspections: Dr. Jones advises scheduling regular mould and air quality inspections, especially after events like water damage.
- Proper Ventilation: Ensuring your home is well-ventilated can help reduce the concentration of indoor pollutants.
- Use of Air Purifiers: High-efficiency particulate air (HEPA) filters can effectively reduce airborne particles.
- Safe Cleaning Practices: Opt for eco-friendly and non-toxic cleaning products to minimize chemical exposure.
The Role of Mould Inspections: Mould is a common problem in many homes, particularly in areas with high humidity. Dr. Jones explains that mould can grow rapidly after water damage, often within 24-48 hours. Regular mould inspections can help identify hidden mould growth, preventing health issues and structural damage.
Emerging Fungal Threat: Mucormycosis and COVID-19: Mucormycosis, an aggressive opportunistic fungal infection caused by fungi of the order Mucorales, has garnered significant attention in the context of COVID-19. Patients with severe underlying immunosuppression, uncontrolled hyperglycemia, ketoacidosis, iron overload, and those on corticosteroid therapy are particularly susceptible to mucormycosis (Darazam, 2023). The emergence of mucormycosis as a complication of COVID-19 has raised concerns due to its rapid progression, significant morbidity, and mortality rates (Rodrigues et al., 2022).
Understanding Mucormycosis: Mucormycosis can present in various clinical forms, including rhino-orbital, pulmonary, and cutaneous mucormycosis (Zareshahrabadi et al., 2022). The use of systemic steroids, prolonged hospitalization, mechanical ventilation, and uncontrolled diabetes have been identified as risk factors for COVID-19-associated mucormycosis (CAM) (Swain, 2021). The deadly triad of COVID-19 infection, diabetes, and the widespread use of corticosteroids has contributed to the increased incidence of mucormycosis during the pandemic (Ravi et al., 2022).
Environmental Factors and Transmission: Mucorales fungi are commonly found in the environment and can become airborne. The spores are a significant mode of transmission, with inhalation being a common route of entry into the human body. These fungi grow on decaying vegetable matter and are known to produce spores that can become airborne, posing a risk of infection, particularly in individuals with predisposing conditions such as diabetes, immunocompromised states, or those undergoing specific medical treatments (Watkins & Thomas, 1998; Gupta et al., 2022).
Preventive Measures and Early Detection: Prompt diagnosis and treatment of mucormycosis in COVID-19 patients are essential to mitigate mortality and morbidity rates (K. et al., 2022). The surge in mucormycosis cases during the COVID-19 pandemic has posed a significant challenge, particularly in regions like India (Kumar et al., 2022). Understanding the risk factors and appropriate interventions is crucial for managing this complex co-occurrence (Aranjani et al., 2021).
Conclusion: Maintaining good indoor air quality and addressing mould issues promptly are essential steps in safeguarding your family’s health. By following Dr. Cameron Jones' expert tips, homeowners can create a safe and healthy living environment. Additionally, staying informed about emerging fungal threats like mucormycosis, particularly in the context of COVID-19, underscores the importance of vigilance, early detection, and targeted management strategies.
References
• Darazam, I. A., Babamahmoodi, A., Ebrahimi, M. J., Moafi, M., Dilmaghani, N. A., Mardani, M., … & Hallajnejad, M. (2023). Mucormycosis, new causative agents, and new susceptible populations: review of cases in a tertiary care hospital in iran (2007-2021). Iranian Journal of Public Health. https://doi.org/10.18502/ijph.v52i11.14046
• Rodrigues, M. G., Sekiguchi, W. K., Gonçalves, S., Casal, Y. R., Frassetto, F. P., Silva, V. T. G. d., … & Magri, M. M. C. (2022). Loss of an eye to mucormycosis following corticosteroid therapy for covid-19. Autopsy Case Reports, 12, e2021345. https://doi.org/10.4322/acr.2021.345
• Khatri, A., Chang, K., Berlinrut, I., & Wallach, F. (2021). Mucormycosis after coronavirus disease 2019 infection in a heart transplant recipient – case report and review of literature. Journal of Medical Mycology, 31(2), 101125. https://doi.org/10.1016/j.mycmed.2021.101125 • Zareshahrabadi et al., 2022
• Swain, S. K. (2021). Covid-19 associated mucormycosis in head and neck region of pediatric patients: a life-threatening disease in current pandemic. International Journal of Contemporary Pediatrics, 8(7), 1322. https://doi.org/10.18203/2349-3291.ijcp20212500
• Swain, S. K. (2021). Covid-19 associated mucormycosis in head and neck region of pediatric patients: a life-threatening disease in current pandemic. International Journal of Contemporary Pediatrics, 8(7), 1322. https://doi.org/10.18203/2349-3291.ijcp20212500
• K., S. R., Ali, T., Deepthi, P. N., Saranya, C. K., & Payyappilly, R. J. (2022). Covid-19-associated mucormycosis: case series from a tertiary care hospital in south india. Access Microbiology, 4(6). https://doi.org/10.1099/acmi.0.000360
• Kumar, A., Verma, M. K., Hakim, A., Sharma, S., Meena, R., & Bhansali, S. (2022). Epidemiology of mucormycosis cases during the second wave of covid-19 in a tertiary care institute in western rajasthan, india. Cureus. https://doi.org/10.7759/cureus.22973
• Aranjani, J. M., Manuel, A., Razack, H. I. A., & Mathew, S. T. (2021). Covid-19–associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic’s second wave in india. PLOS Neglected Tropical Diseases, 15(11), e0009921. https://doi.org/10.1371/journal.pntd.0009921
• Aranjani, J. M., Manuel, A., Razack, H. I. A., & Mathew, S. T. (2021). Covid-19–associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic’s second wave in india. PLOS Neglected Tropical Diseases, 15(11), e0009921. https://doi.org/10.1371/journal.pntd.0009921
• Aranjani, J. M., Manuel, A., Razack, H. I. A., & Mathew, S. T. (2021). Covid-19–associated mucormycosis: evidence-based critical review of an emerging infection burden during the pandemic’s second wave in india. PLOS Neglected Tropical Diseases, 15(11), e0009921. https://doi.org/10.1371/journal.pntd.0009921
• Gunathilaka, M. G. R. S. S., Senevirathna, R. M. I. S. K., Illappereruma, S. C., Keragala, K. A. R. K., Hathagoda, K. L. W., & Bandara, N. (2023). Mucormycosis-causing fungi in humans: a meta-analysis establishing the phylogenetic relationships using internal transcribed spacer (its) sequences. Journal of Medical Microbiology, 72(2). https://doi.org/10.1099/jmm.0.001651
• O’Connor, C., Farrell, C., Fabre, A., Eaton, D., Redmond, K., Conneely, J. B., … & Hannan, M. M. (2018). Near-fatal mucormycosis post-double lung transplant presenting as uncontrolled upper gastrointestinal haemorrhage. Medical Mycology Case Reports, 21, 30-33. https://doi.org/10.1016/j.mmcr.2018.03.009
• Bouza, E., Muñóz, P., & Guinea, J. (2006). Mucormycosis: an emerging disease?. Clinical Microbiology and Infection, 12, 7-23. https://doi.org/10.1111/j.1469-0691.2006.01604.x
• Bouza, E., Muñóz, P., & Guinea, J. (2006). Mucormycosis: an emerging disease?. Clinical Microbiology and Infection, 12, 7-23. https://doi.org/10.1111/j.1469-0691.2006.01604.x
• Waseem, M., Zahera, M., & Gopalakrishnaiah, V. (2017). Isolated pulmonary cavitary mucormycosis in uncontrolled diabetic, diagnosed by fiber-optic bronchoscopy and completely managed medically. International Journal of Research in Medical Sciences, 5(12), 5462. https://doi.org/10.18203/2320-6012.ijrms20175475
• Tyagi, A., Grover, S., & Bansal, R. (2022). Changing faces and habitat of mucormycosis epidemic in sequential covid waves. Indian Journal of Pathology and Oncology, 9(3), 227-231. https://doi.org/10.18231/j.ijpo.2022.054
• Hogan, L. H., Klein, B. S., & Levitz, S. M. (1996). Virulence factors of medically important fungi. Clinical Microbiology Reviews, 9(4), 469-488. https://doi.org/10.1128/cmr.9.4.469
• Voitl, P., Scheibenpflug, C., Weber, T., Janata, O., & Am, R. (2002). Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin b. European Journal of Clinical Microbiology and Infectious Diseases, 21(8), 632-634. https://doi.org/10.1007/s10096-002-0781-6
• Songu, M., Ünlü, H., Günhan, K., İlker, S. S., & Neşe, N. (2008). Orbital exenteration: a dilemma in mucormycosis presented with orbital apex syndrome. American Journal of Rhinology, 22(1), 98-103. https://doi.org/10.2500/ajr.2008.22.3121
• Shariati, A., Moradabadi, A., Chegini, Z., Khoshbayan, A., & Didehdar, M. (2020). <p>an overview of the management of the most important invasive fungal infections in patients with blood malignancies</p>. Infection and Drug Resistance, Volume 13, 2329-2354. https://doi.org/10.2147/idr.s254478
• Kim, N., Han, S. H., Park, H. Y., Kim, H. W., Ren, H., Choi, N. G., … & Shin, B. C. (2018). Successful treatment of invasive gastric mucormycosis in a kidney transplant recipient. Korean Journal of Transplantation, 32(4), 104-107. https://doi.org/10.4285/jkstn.2018.32.4.104
• Munir, N. and Jones, N. S. (2006). Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management. The Journal of Laryngology &Amp; Otology, 121(2), 192-195. https://doi.org/10.1017/s0022215106003409
• Hamilos, G., Samonis, G., & Kontoyiannis, D. P. (2011). Pulmonary mucormycosis. Seminars in Respiratory and Critical Care Medicine, 32(06), 693-702. https://doi.org/10.1055/s-0031-1295717
• Sugar, A. M. (1992). Mucormycosis. Clinical Infectious Diseases, 14(Supplement_1), S126-S129. https://doi.org/10.1093/clinids/14.supplement_1.s126